Feedback plc (AIM: FDBK) – positive new start for the medical software company
This week Feedback plc (AIM: FDBK), the medical imaging software company, announced the adoption of its TexRAD research software by four leading cancer research institutions. This continues the good momentum for the Group, who last week announced that they had signed a research agreement with Oxford Stone Group at the University of Oxford, to investigate the potential clinical application of the TexRAD software on CT image data of patients with kidney stones.
TexRAD analyses the textures in radiological scans to assist clinicians in assessing the prognosis, risk and treatment of patients. The software was developed by TexRAD LTD which was acquired by Feedback in May 2014 along with complimentary business Cambridge Computed Imaging LTD (CCI).
The acquisitions represent a ‘new era’ for Feedback, which was first incorporated in 1958. However, following a number of years of falling sales Feedback sold…
Previous article Next article
